Day: June 3, 2024

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

– Ongoing Phase 1a first-in-human clinical trial continues to demonstrate proof of concept for the UNO solid tumor platform with observed early tumor responses and clinical resolution of radiation dermatitis – Phase 1a data continue to support feasibility of administering UNO at ultra-high concentrations with immune biomarkers at 50,000 parts per million (ppm) demonstrating an immunogenic response – Phase 1b protocol of UNO in combination with anti-PD-1 antibody therapy filed for regulatory approval – Phase 1a clinical data and Phase 1b study design unveiled at 2024 American Society of Oncology Annual Meeting HAMILTON, Bermuda, June 03, 2024 (GLOBE NEWSWIRE) — Beyond Cancer, Ltd., a clinical-stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, announced encouraging...

Continue reading

Smart Share Global Limited Announces First Quarter 2024 Results

POIs1 operated through network partner model reached 79.7% as of the end of the first quarter of 2024Cumulative registered users2 reached 404.3 million as of the end of the first quarter of 2024 SHANGHAI, China, June 03, 2024 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended March 31, 2024. HIGHLIGHTS FOR THE FIRST QUARTER OF 2024 As of March 31, 2024, 79.7% of POIs were operated under our network partner model, compared with 72.8% as of December 31, 2023. As of March 31, 2024, the Company’s services were available in 1,245 thousand POIs, compared with 1,234 thousand as of December 31, 2023. As of March 31, 2024, the Company’s available-for-use power...

Continue reading

G2 drills 46.5 m @ 1.1 g/t Au at NW OKO Discovery

TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to provide an update on the Company’s new discovery at NW OKO, part of the 27,719-acre OKO-AREMU gold project, Guyana. G2 recently announced an updated Mineral Resource Estimate (“MRE”) for the project comprised of 922,000 ounces of gold (“Indicated”) and 1,099,000 ounces of gold (“Inferred”) [see press release dated April 03, 2024]. The NW OKO discovery lies an approximate distance of 3.5 km from the current established gold resource at the OKO Main/Ghanie areas [see press release dated February 13, 2024], opening up a new district for resource expansion. Geologically, NW OKO is very similar to the OKO Main/Ghanie Zone, featuring long prominent shear structures that host mineralized quartz veins which are situated...

Continue reading

Great Quest Appoints Dr. Andreas Rompel as President and VP Exploration

VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) — Great Quest Fertilizer Ltd (TSXV:GQ) (“Great Quest” or the “Company”) is pleased to announce the appointment of Dr. Andreas Rompel as President and Vice President of Exploration of the Company. The appointment marks the completion of a transition to gold exploration across Africa, focused on Namibia. Former President Jed Richardson will transition to the role of Executive Chairman. Dr. Andreas Rompel (Andy), has more than 35 years of management, operating and technical experience in the mining industry. Dr. Rompel was previously the President & CEO of the Cobalt Power Group, a position to which he was appointed in 2016. Dr. Rompel and his team successfully kick-started exploration resulting in a seven-fold return for investors during his tenure. Dr. Rompel has held...

Continue reading

Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on June 5, 2024

Shoham, Israel, June 03, 2024 (GLOBE NEWSWIRE) —  Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced its CEO and Co-Founder, Oren Elkayam, will participate in a fireside chat at the Maxim Group Virtual TMT Conference at 8:30 am ET on Wednesday, June 5, 2024 with Maxim’s Senior Analyst. As a leader in cybersecure, hardware and software solutions to the drones, robotics, and autonomous vehicles market, Mobilicom addresses a market forecast that is expected to reach $8.5 billion by 2026. The Company’s customers include some of the largest Tier-1 drone manufacturers who sell drones that integrate Mobilicom’s solutions into the world’s leading defense organizations.    This conference will be live on M-Vest. To attend, sign up to become an M-Vest member.     ...

Continue reading

Goliath Mobilizes For 15,000 Meter Drill Program To Test Surebet Feeder Source Plus Three New High-Grade Gold-Copper Targets Outcropping On Golddigger, Golden Triangle, B.C.

Infographic 1 Infographic 1 Infographic 2 Infographic 2 Infographic 3 Infographic 3 Infographic 4 Infographic 4 Infographic 5 Infographic 5 Infographic 6 Infographic 6 The 2024 planned drill campaign at the Golddigger Property includes 62 holes from 22 drill pad locations with up to three diamond drill rigs for 15,000 meters. The Surebet Discovery will see the vast bulk of meters planned with the balance testing three new highly mineralized gold-copper outcropping targets: Jackpot, Treasure Island and Full Contact that have the potential to provide additional upside catalysts for shareholders (see drill location map below). An accompanying infographic is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/4623943b-d843-44a9-a54e-a2f7f0e22b1f Surebet Discovery Surebet’s meters...

Continue reading

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s disease ~ ~ Receiving RMAT designation enables increased collaboration with the FDA on regulatory approval planning, in addition to the opportunity for expedited product development ~ LEXINGTON, Mass. and AMSTERDAM, June 03, 2024 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its investigational gene therapy AMT-130 for the treatment of Huntington’s disease. The FDA granted RMAT designation based...

Continue reading

Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production

ANN ARBOR, Mich., June 03, 2024 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces today that Kraig Labs is now in production with its BAM-1 recombinant spider silk hybrids. The Company originally planned this launch for July, but the resounding successes of the production trials positioned Kraig Labs to accelerate its 2024 production schedule. This production cycle serves as a critical transition for the Company’s commercialization of sustainable and cost-effective spider silk production. This announcement marks the Company’s first transition of true production hybrids to the manufacturing environment. This rearing cycle also represents more than a 10X increase in production over the spring trials and is the largest single batch of spider...

Continue reading

Enthusiast’s Luminosity Hosts Get On My Level X to Over 200,000 Unique Online Viewers

Get On My Level X reached over 200,000 unique online viewers, 60,000 concurrent viewers, and 2,500 live in-person attendees LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming and media company, today announced that its 10th anniversary edition of the Get On My Level event, hosted by Luminosity in partnership with Even Matchup Gaming, reached over 200,000 unique online viewers and peaked at over 60,000 concurrent online viewers while hosting a standing-room-only in-person crowd. The event was held at the Sheraton Centre Toronto Hotel where over 2,500 live attendees participated in three days of live entertainment and high stakes competition, featuring a variety of fighting game titles, headlined by Super Smash Bros Melee and Super Smash...

Continue reading

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. Jefferies Global Healthcare Conference 2024:On Thursday, June 6th, at 1:30 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude will participate in a fireside chat. A live webcast of the fireside chat can be accessed here. Goldman Sachs 45th Annual Global Healthcare Conference:On Wednesday, June 12th, at 10:40 a.m. ET, Dr. Vaddi will provide a corporate presentation. The live webcast of the presentation can be accessed here. For more information, visit Prelude’s website under Events and Presentations. All webcast recordings will be archived and available on the Company’s website...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.